semaglutide and aod 9604 Metabolic Research Bundle Kit | Tirzepatide + + AOD-9604 AOD 9604 vs. Semaglutide |

[1] [2] Other serious risks include pancreatitis, gallbladder disease, acute kidney injury, and diabetic retinopathy complications

Caveats Intervals of semaglutide use were defined using prescription data

Despite advances in the development of therapeutics, morbidity and mortality rates remain high

Among 11,558 semaglutide-related reports, researchers identified 417 cases specifically related to visual impairment, retinopathy, or ischemic optic neuropathy

Adverse events included gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones